Fulcrum Therapeutics, Inc. (FULC) Social Stream



Fulcrum Therapeutics, Inc. (FULC): $5.14

0.03 (+0.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FULC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Fulcrum Therapeutics Inc (FULC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering FULC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-10 6 $46 $16 $36.333 $24 51.39%
2022-02-01 6 $46 $16 $34.833 $24 45.14%
2022-03-04 6 $46 $16 $34.833 $24 45.14%
2022-03-07 6 $43 $16 $33.833 $24 40.97%
2022-03-08 7 $43 $16 $33.714 $24 40.47%
2022-03-30 7 $43 $18 $34 $24 41.67%

The Trend in the Analyst Price Target


Over the past 43 weeks, FULC's average price target has gone up $14.87.

Over the past 51 weeks, FULC's average upside potential has been 96.77%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 4 39 11 20.880 9.00 132%
2021-08-01 4 39 11 20.880 7.31 185.64%
2021-09-04 7 46 12 34.860 28.07 24.19%
2021-11-19 6 46 16 36.333 17.14 111.98%
2022-03-07 7 43 16 33.833 14.90 127.07%

FULC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.36 5 1 1 0 0 7

The Trend in the Broker Recommendations


Over the past 30 weeks, FULC's average broker recommendation rating improved by 0.71.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Fulcrum Therapeutics Inc's variance in analysts' estimates is lower than -418.36% of them.
  • Fulcrum Therapeutics Inc's number of analysts covering the stock is higher than 492.81% of stocks in the small market cap category.
  • FULC has a higher upside potential (average analyst target price relative to current price) than 123.34% of Pharmaceutical Products stocks.
  • FULC has a greater average analyst price target than 449.04% of stocks in the small market cap category.

Stocks similar to Fulcrum Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FREQ, FIXX, and FHTX.

Is FULC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4153 seconds.